water corpor water engag analyt instrument manufactur design sell servic water
divis high perform liquid chromatographi hplc ultra perform liquid chromatographi uplc mass spectrometri ms
instrument system support product includ chromatographi column consum product post-warranti servic
plan ta divis ta compani design manufactur sell servic thermal analysi rheometri calorimetri
instrument compani also develop supplier software-bas product interfac compani instrument
well manufactur instrument compani product use pharmaceut life scienc biochem industri
academ govern custom work research develop laboratori applic compani oper
two segment water divis ta divis
rank
incom statement summari figur million
global peer group analysi figur usd
hi
long-term fundament rank
short-term technic rank
water rank number list medic equip
compani trade today unit state market
capit billion
medic equip compani highest total
asset highest revenu
within sector rel low price-to-earnings low p/e/g
moder p/
final earn growth past month
stock score set
involv valuat size
financi perform
rank accord
averag valu
rank lowest
rank
price chang neg short-term day
medium-term month period year short
term fall combin weak volum result weak
momentum fall day
significantli price discount
move averag price rang
trade discount
high premium
low invest exactli one year ago worth
capit loss
stock score set
price perform trade
volum rank
accord averag
valu paramet
highest rank
lowest rank
water corpor place bss rank nyse perform past year percentil rank
water corpor largest revenu forb global
rank citi top global cash cow reinvest-to-payout ratio
total bracket
revenu billion aggreg sector revenu
billion previou year
net profit million aggreg sector net profit
billion previou year
ebit million aggreg sector ebit
billion previou year
mcap billion aggreg sector mcap
billion previou year
price-to-earnings versu sector averag
earn yield time bond yield
averag annual compound return share price
last year exceed averag annual
compound return
total liabilities/ebitda less compar
favour joseph piotroski benchmark
return asset versu sector averag
market averag
return capit employ versu sector averag
market averag
net profit margin averag last year
consid superior suggest high margin safeti
market capit increas billion
billion billion last year
increas compris cumul retain earn rete
billion creat market valu billion
creat market valu multipl defin chang
mcap everi retain earn
ebit margin posit seen consecut rise last
price/mov averag price macd
price/map lower price/map
indic exponenti move averag ema
minu ema neg
suggest bearish signal ema well
ema fall anoth bearish signal
price emap ratio past day
ratio time suggest downsid
emap decreas decreas
anoth bearish indic
price/map lower
price/map
past day ratio time
suggest downsid stock trade
map map lower
map bearish indic
map decreas decreas anoth
price map ratio bearish indic
past week volum time averag
share thursday close price
discount volum weight averag price vwap
present valu invest one month
ago capit loss
last three month stock hit new low
ten time point signific downtrend
price/earnings/growth base year-on-year
growth trail month ep versu sector
averag
price/sal versu sector averag market
averag estim share trade
current year price/sal forward year price/sal
tobin ratio defin mcap divid total asset
compar rest market stock
overvalu rank bottom stock valu
earn yield less benchmark yield
discount high
jan also premium low
volum index average
stock trade low
high averag daili volatil place
stock quartil market mean mildli
result report
us thousand except per share data share outstand
cost oper expens
product sale
servic sale
sell administr expens
research develop expens
total cost oper expens
incom incom tax
provis incom tax
weighted-averag number basic common share
weighted-averag number dilut common share
unreal gain invest incom tax
unreal gain invest net tax
retir liabil adjust reclassif
amount reclassifi incom
retir liabil adjust incom tax
retir liabil adjust net tax
cash equival
properti plant equip net
note payabl debt
defer revenu custom advanc
long-term portion retir benefit
commit conting note
author none issu march decemb
author share issu
share outstand march decemb
treasuri stock cost share march
decemb respect
accumul comprehens loss
total liabil stockhold deficit
flow oper activ
adjust reconcil net incom net cash provid
amort intang
chang oper asset liabil
decreas account receiv
increas inventori
increas current asset
decreas asset
decreas account payabl current liabil
increas defer revenu custom advanc
effect tax job act
increas decreas liabil
net cash provid oper activ
flow invest activ
addit properti plant equip softwar
busi acquisit net cash acquir
purchas invest
matur sale invest
net cash use provid invest activ
flow financ activ
proce debt issuanc
payment debt
proce stock plan
purchas treasuri share
proce deriv contract
net cash provid use financ activ
effect exchang rate chang cash cash equival
increas decreas cash cash equival
cash equival begin period
cash equival end period
quarterli report sequenti growth
nyse announc ep quarter-end march sequenti
previou quarter
sequenti growth ep
sequenti growth revenu
sequenti growth net profit
compar previou correspond period pcp year-over-year ep revenu
net profit
pcp growth ep
pcp growth revenu
pcp growth net profit
major chang compar previou correspond period vs
net profit slump
total revenu
ebit sale
profit tax sale
profit tax sale
tax expens sale
result report annual
us thousand except per share data share outstand
cost oper expens
product sale
servic sale
sell administr expens
research develop expens
acquir in-process research develop
total cost oper expens
incom incom tax
provis incom tax
weighted-averag number basic common share
weighted-averag number dilut common share
cash equival
properti plant equip net
note payabl debt
defer revenu custom advanc
long-term portion retir benefit
author none issu decemb
author share issu
share outstand
treasuri stock cost share
respect
accumul comprehens loss
total liabil stockhold deficit equiti
flow oper activ
adjust reconcil net incom net cash provid
amort intang
in-processresearch develop non-cash charg
chang oper asset liabil net acquisit
increas account receiv
increas decreas inventori
increas current asset
increas decreas asset
increas decreas account payabl current
increas defer revenu custom advanc
effect tax job act
decreas increas liabil
net cash provid oper activ
flow invest activ
addit properti plant equip softwar
asset busi acquisit net cash acquir
invest unaffili compani
payment intellectu properti licens
purchas invest
matur sale invest
net cash provid use invest activ
flow financ activ
proce debt issuanc
payment debt
payment debt issuanc cost
proce stock plan
purchas treasuri share
proce payment deriv contract
net cash use financ activ
effect exchang rate chang cash cash equival
decreas increas cash cash equival
cash equival begin period
cash equival end period
earn cont op margin
annual report water revenu
nyse report total revenu year-end decemb
previou year earn per share ep
major chang compar previou year vs
ep
ebit total asset
total revenu total asset
retain earn total asset
total non-curr asset total asset
current debtor total asset
fix asset total asset
good sold sale
current ratio
work capit total asset
total current asset total asset
net profit steadi
ebit margin steadi
profit tax sale
sale market expens sale
intang total asset
profit/ loss tax
year-on-year comparison per share figur vs
year-on-year comparison perform ratio vs
return asset
total liabil ebitda
total liabil oper
common size ratio asset
total current asset total asset
total non-curr asset total asset
intang total asset
current debtor total asset
fix asset total asset
common size ratio sale
good sold sale
profit tax sale
sale market expens sale
tax expens sale
five-year record growth perform
last year total revenu averag ebitda averag net profit averag
compound annual growth rate compound-annual-growth-rate averag total revenu net profit ebitda
five-year record ebitda oper profit net profit roa roce
net profit margin average figur
return asset
return capit employ
profit tax
oper cash flow
sale
past year incom tax profit tax decreas
report buy sell trail month continu
share
report institut buy sell share
hold end quarter
report hold institut decemb
total report hold institut share
report hold institut
issu capit
net buying/ sell institut trail month ttm
usd valu
new york mellon corp
commonwealth bank australia
scotia
america corp de
employe retir system
teacher retir system texa
new patent issu us pto
view detail click patent link
system method devic address sampl extract inject problem chromatographi
diffus assembl associ method
structur elucid isotop label analyt
devic method use porou media fluidic devic
cool liquid eluent carbon dioxid chromatographi system gas-liquid separ
techniqu process mass spectral data
bear particular magnet levit assembl
auto-sampl system automat acquir sampl
method extend dynam rang absorb detector
thermal isol fluidic block activ control thermistor
rotari rheomet dual read head optic encod
method detect quantifi non-polar analyt high sensit
techniqu qualif mainten scientif inform system devic
fluidic fit integr face seal
chiral separ relat enantiom use
method liquid chromatographi calibr rapid label n-glycan
sensor bodi flow pressur sensor
analysi complex biolog matric target advanc precursor product ion
autom sampl reaction system high pressur liquid chromatographi type
techniqu acceler thermal equilibrium chromatograph column
calorimet diffusion-bond block
dmd base uv absorpt detector liquid chromatographi
rotari inject valv intern sampl load channel
liquid chromatographi conduit assembl high pressur seal
mobil phase control supercrit fluid chromatographi system
fluoresc tag glycan biomolecul enhanc ms signal
method system screen cell organoid
valv protect coat
method determin rel respons factor impur analysi use liquid chromatographi
absorb evapor light scatter detect
method prepar liquid mixtur
techniqu thermal insul liquid chromatograph column
fluoresc tag glycan biomolecul enhanc ms signal
molecular diagnost person dermatolog dermatopatholog cosmet
regul improv thermal pressur control chromatographi
method reduc chromatograph band broaden separ devic
apparatu method analyt extract
method perform chromatographi inject sequenc use singl inject valv
rotari shear valv two-pin drive shaft liquid chromatographi applic
pressur monitor optim fluid path util
passiv column pre-heat use chromatograph system
column manag multi-zon thermal system use liquid chromatographi
stir paddl isotherm titrat calorimetri
establish fluidic connect chromatographi compon
check valv polymer seat poppet
apparatu method prepar liquid chromatographi
seal assembl reciproc rotari applic
composit method kit quantifi target analyt sampl
porou materi devic perform separ filtrat catalysi ek pump
method make use
devic use solid-st nmr analysi
static spatial thermal gradient chromatographi analyt scale
porou materi solid phase extract chromatographi process prepar use
rotari selector valv associ system method
hybrid gradient deliveri system oper
select method separ ondansetron relat impur
method quantifi polypeptid use mass spectrometri
corros protect tube use chromatographi
profil diagnost person dermatolog dermatopatholog cosmet
flame ioniz detect burner assembl use compress fluid-bas chromatographi
atmospher interfac electr ground electrospray
split supercrit fluid chromatographi system
high puriti chromatograph materi compris ioniz modifi
degass liquid eluent prepar sfc fluid chromatographi system
electromechan fluidic interfac microfluid substrat
sampl system method use
cell differenti refract index detect
catalyt oxid polar modifi chromatograph mobil phase
method gener gradient flow constant composit nois characterist
materi hydrophil interact chromatographi process prepar use thereof
analysi glycoprotein glycopeptid
method apparatu analyz complex sampl
nanocomposit applic monolith column
chromatograph materi separ unsatur molecul
apparatu method creat static travers thermal gradient microfluid devic
gradient system method
high pressur fit supercrit fluid chromatographi
method high pressur gradient chromatographi use pump stroke control
liquid-chromatographi apparatu diffusion-bond titanium compon
analysi dri blood spot sampl microfluid system dilut extract sampl
reusabl fit attach conduit port
techniqu autom softwar test
thermal modul variabl restrictor normal dynam split ratio
dispens needl fraction collector
system method refract index detect
porou inorganic/organ homogen copolymer hybrid materi chromatograph separ
process prepar thereof
method quantifi polypeptid use mass spectrometri
water corpor water engag analyt instrument manufactur design sell servic
water divis high perform liquid chromatographi hplc ultra perform liquid chromatographi
uplc mass spectrometri ms instrument system support product includ chromatographi column
consum product post-warranti servic plan ta divis ta compani design
manufactur sell servic thermal analysi rheometri calorimetri instrument compani also
develop supplier software-bas product interfac compani instrument well
manufactur instrument compani product use pharmaceut life scienc biochem
industri academ govern custom work research develop laboratori
applic compani oper two segment water divis ta divis
earn per share ep
board manag creation sharehold valu
board director year sinc appoint
board manag
presid ta
mr connel serv chairman board
januari serv presid chief execut
offic director compani august
august mr connel serv execut vice presid
presid restor therapi group medtron
plc august mr connel serv
follow posit plc senior vice presid
presid diabet presid physio-
control vice presid sale market cardiac
patient manag busi vice presid corpor
strategi director investor relat corpor
mr connel year progress leadership
posit prior provid overal strateg direct
oper manag restor
therapi group five divis well led integr
group activ within overal strategi
dr ornskov serv director compani sinc
june januari march dr
ornskov serv advisor ceo takeda
pharmaceut compani ltd serv chief execut
offic design well board member shire plc
januari chief execut offic april
januari serv
chief market offic global head strateg market
gener specialti medicin bayer ag
serv global presid
over-the-counter bausch lomb inc also serv
chairman later presid chief execut
offic life-cycl pharma a/ serv
presid chief execut offic ikaria inc
pharmaceut career role increas respons
merck co inc novarti ag
dr ornskov bring oper medic knowledg
along extens intern strateg oper
experi pharmaceut sector senior leadership
board level
nomin corpor govern committe
scienc technolog committe
former public compani directorship held past
ms baddour serv director compani sinc
septemb june septemb ms
baddour serv execut vice presid chief
offic may may
chief offic account offic
april chief account offic
pharmaceut product develop inc
ms baddour corpor control
product develop inc serv
control cooper bank save inc
ms baddour extens experi senior financi
execut provid water board signific account
financ health care industri expertis
former public compani directorship held past
dr glimcher serv director compani sinc
januari dr glimcher presid chief execut
offic dana-farb cancer institut princip
investig director dana-farber/harvard cancer
center richard susan smith professor medicin
harvard medic school januari june dr
glimcher serv stephen suzann weiss dean
weill cornel medic colleg provost medic affair
cornel univers dr glimcher serv
iren heinz given professor immunolog harvard
school public health professor medicin harvard
physician scientist professor dr glimcher bring
divers technic skill experi water board
fellow american academi art scienc
member nation academi scienc
institut medicin nation academi scienc
nomin corpor govern committe
scienc technolog committe chair
former public compani directorship held past
mr salic serv director compani sinc
juli mr salic co-found manag member
sfw capit partner llc privat equiti firm serv
manag member sfw capit partner llc sinc
januari june decemb mr salic
serv varieti capac aea investor inc
includ manag director presid chief execut
offic vice-chairman mr salic director sever
privat held compani filtec gerson lehrman group inc
year experi privat equiti
busi mr salic bring water board in-depth
experi strateg plan financ capit structur
merger acquisit
nomin corpor govern committe chair
former public compani directorship held past
mr kuebler serv director compani sinc
may independ director investor
sinc serv chairman chief execut offic
covanc inc predecessor compani novemb
decemb chairman prior
join covanc inc mr kuebler spent nearli year
pharmaceut industri squibb inc
monsanto compani
year experi pharmaceut
pharmaceut servic industri includ year
chairman chief execut offic covanc inc mr
kuebler bring experienc manag perspect
water board well expertis oversight
financi account busi strategi
former public compani directorship held past
ms reed serv director compani sinc
may ms reed health care servic consult
sinc april april advisor
chief execut offic medco health solut inc
march ms reed serv senior vice presid
financ chief offic medco health solut
inc serv senior vice presid
financ medco health solut inc join medco
contain servic inc prior experi includ
employ cb inc aetna/american re-insur co
standard poor financi servic llc
mr hendrickson serv director compani
sinc septemb independ director
investor sinc june june june
serv chief execut offic valspar corpor
june june also serv
chairman februari june also serv
presid februari june mr
hendrickson serv follow posit valspar
corpor chief oper offic group vice presid
global wood coat senior vice presid architectur
global wood coat feder busi unit
corpor vice presid presid asia pacif
ms reed extens experi senior financi execut
provid water board signific account financ
health care industri expertis
mr hendrickson year experi presid chief
execut offic chairman afford board
benefit consider financi account busi
former public compani directorship held past
former public compani directorship held past
mr conard serv director compani sinc
august independ director investor
sinc januari mr conard manag director bain
capit llc march decemb mr conard
previous director wasserstein perella co inc
invest bank firm special merger
acquisit vice presid bain compani head
firm oper practic area
mr conard year experi director manag
director two larg invest firm afford water board
benefit consider financi account busi
former public compani directorship held past
dr berendt serv director compani sinc
march sinc decemb dr berendt life
scienc industri consult novemb novemb
dr berendt chief execut offic chief
scientist telesta juli novemb
dr berendt life scienc industri consult
march juli dr berendt serv presid
chief execut offic inc
august decemb dr berendt serv manag
director research corpor technolog inc
novemb august dr berendt serv manag
director aea investor lp dr berendt also work
year pharmaceut industri
serv number senior manag posit includ
senior vice presid research pharmaceut
divis bayer corpor group director drug
discoveri inc
dr berendt experi pharmaceut industri
manag scientif perspect provid uniqu
technic insight water board addit dr berendt
year experi chief execut offic senior
financi execut afford board benefit
financi busi strategi skill
scienc technolog committe
former public compani directorship held past
present valu invest year/ year ago
return asset
volum weight averag price vwap summat
turnov divid total volum period
price period/numb period
number share trade period/averag number share
trade period
report report prepar minkabu infonoid inc minkabu analyst opinion project report
suppli global market intellig llc compani profil company-rel inform co-own
minkabu infonoid inc pk clean ltd buysellsign group compani stock index price suppli
stock exchang tradeg exchang euronext deutsch brse ag bme stuttgart stock exchang tradeg exchang
nasdaq stock market hong kong exchang clear limit taiwan stock exchang tokyo stock exchang nagoya stock
express opinion analyst sole person opinion author contributor report minkabu
respons accuraci complet reliabl timeli inform opinion respons error
omiss therein assum liabil direct indirect loss damag particular lost profit may
incur result relianc inform use report inform report may contain project
opinion assumpt estim forecast relat futur busi perform event intend exampl
repres predict minkabu current futur perform compani secur
minkabu make warranti regard accuraci reliabl project opinion assumpt estim forecast
liabil damag kind aris relianc inform forward-look statement guarante
futur perform involv risk uncertainti actual result may differ forward-look statement result
variou factor minkabu oblig updat correct inform report constitut recommend
make invest purchas sell specif invest product report intend give financi
invest advic conduct care independ analysi seek advic profession advisor
suitabl invest need minkabu express opinion compani secur invest
product fluctuat futur perform thereof stock price rate comment includ target price buy
sell hold creat aggreg opinion individu investor opinion analyst secur
compani rate overvalu under-valued fairlyvalu fair stock price other display ancillari
rate object fact base statist record minkabu express opinion compani secur
invest product fluctuat futur perform thereof therebi either
minkabu repres warrant report appropri avail view download locat
exclus respons complianc applic local law regul view download report report
intend use inform refer purpos constitut solicit offer make
invest purchas sell specif invest product
minkabu regist broker dealer invest advisor analyst invest banker underwrit minkabu may hold
secur refer report includ deriv instrument may busi relat compani discuss
herein without prior written consent minkabu reproduct copi transmiss transfer distribut public
similar action content report shall made
